pharma
Paxlovid
Paxlovid drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
NEW YORK, NY, JP HQ
PMDA registrant Type
Company details
- Status
- Public
- HQ
- NEW YORK, NY, JP
- Programs
- 0
- Drugs
- 0
- Patents
- 193
Paxlovid pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Paxlovid drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.